Logo image of FRSX

FORESIGHT AUTONOMOUS-SP ADR (FRSX) Stock Fundamental Analysis

NASDAQ:FRSX - Nasdaq - US3455232039 - ADR - Currency: USD

0.7613  +0.01 (+1.51%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to FRSX. FRSX was compared to 81 industry peers in the Automobile Components industry. While FRSX has a great health rating, there are worries on its profitability. FRSX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year FRSX has reported negative net income.
FRSX had a negative operating cash flow in the past year.
FRSX had negative earnings in each of the past 5 years.
FRSX had a negative operating cash flow in each of the past 5 years.
FRSX Yearly Net Income VS EBIT VS OCF VS FCFFRSX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -5M -10M -15M -20M

1.2 Ratios

Looking at the Return On Assets, with a value of -99.18%, FRSX is doing worse than 98.77% of the companies in the same industry.
FRSX's Return On Equity of -131.36% is on the low side compared to the rest of the industry. FRSX is outperformed by 90.12% of its industry peers.
Industry RankSector Rank
ROA -99.18%
ROE -131.36%
ROIC N/A
ROA(3y)-63.12%
ROA(5y)-60%
ROE(3y)-75.73%
ROE(5y)-70.94%
ROIC(3y)N/A
ROIC(5y)N/A
FRSX Yearly ROA, ROE, ROICFRSX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 100 -100 150

1.3 Margins

FRSX's Gross Margin of 71.23% is amongst the best of the industry. FRSX outperforms 100.00% of its industry peers.
The Profit Margin and Operating Margin are not available for FRSX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 71.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FRSX Yearly Profit, Operating, Gross MarginsFRSX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -2K -4K -6K -8K -10K

More info and screens

7

2. Health

2.1 Basic Checks

FRSX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, FRSX has more shares outstanding
Compared to 5 years ago, FRSX has more shares outstanding
There is no outstanding debt for FRSX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
FRSX Yearly Shares OutstandingFRSX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
FRSX Yearly Total Debt VS Total AssetsFRSX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

2.2 Solvency

FRSX has an Altman-Z score of -9.60. This is a bad value and indicates that FRSX is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of FRSX (-9.60) is worse than 96.30% of its industry peers.
FRSX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -9.6
ROIC/WACCN/A
WACC9.11%
FRSX Yearly LT Debt VS Equity VS FCFFRSX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M

2.3 Liquidity

A Current Ratio of 7.52 indicates that FRSX has no problem at all paying its short term obligations.
With an excellent Current ratio value of 7.52, FRSX belongs to the best of the industry, outperforming 97.53% of the companies in the same industry.
FRSX has a Quick Ratio of 7.52. This indicates that FRSX is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of FRSX (7.52) is better than 97.53% of its industry peers.
Industry RankSector Rank
Current Ratio 7.52
Quick Ratio 7.52
FRSX Yearly Current Assets VS Current LiabilitesFRSX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

More info and screens

0

3. Growth

3.1 Past

FRSX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.26%, which is quite good.
The Revenue has decreased by -9.64% in the past year.
EPS 1Y (TTM)17.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.57%
Revenue 1Y (TTM)-9.64%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%83.64%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FRSX Yearly Revenue VS EstimatesFRSX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 100K 200K 300K 400K 500K
FRSX Yearly EPS VS EstimatesFRSX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 -5 -10 -15

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for FRSX. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FRSX Price Earnings VS Forward Price EarningsFRSX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FRSX Per share dataFRSX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1 -1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

FRSX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FORESIGHT AUTONOMOUS-SP ADR

NASDAQ:FRSX (3/7/2025, 8:00:01 PM)

0.7613

+0.01 (+1.51%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)11-25 2022-11-25/bmo
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner Change-64.15%
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap11.67M
Analysts82.86
Price TargetN/A
Short Float %2.78%
Short Ratio0.35
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 23.48
P/FCF N/A
P/OCF N/A
P/B 0.83
P/tB 0.83
EV/EBITDA N/A
EPS(TTM)-1.86
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.85
FCFYN/A
OCF(TTM)-0.85
OCFYN/A
SpS0.03
BVpS0.91
TBVpS0.91
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -99.18%
ROE -131.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 71.23%
FCFM N/A
ROA(3y)-63.12%
ROA(5y)-60%
ROE(3y)-75.73%
ROE(5y)-70.94%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 19.25%
Cap/Sales 10.26%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.52
Quick Ratio 7.52
Altman-Z -9.6
F-Score4
WACC9.11%
ROIC/WACCN/A
Cap/Depr(3y)112.84%
Cap/Depr(5y)79.6%
Cap/Sales(3y)92.56%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.57%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.64%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%83.64%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y6.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y15.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.98%
OCF growth 3YN/A
OCF growth 5YN/A